Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Pejman
    Member
    • Jul 2010
    • 23

    #1

    Suspicious results from CuffDiff

    Hey folks
    I'm running CuffDiff from the release 0.9.2, for RNAseq. I use it with tophat, and Reference annotation for human data. Here's the simple running command:


    Code:
    cuffdiff --FDR 0.01 -N hg18_annotation01.gtf accepted_hits1.bam accepted_hits2.bam

    There are few points of concern

    first: over 90% of the genes with "status = OK" have "Significant = yes" which is kinda not so nice.

    second: that there are so many genes with very low FPKM that are among the significant ones, which can also lead to fold changes like: 1.7977e+308 !

    and third: There are genes with large FPKMs that have not been tested (status = NOTEST) , here's some sample, from the file "genes_expr.diff", with a "NOTEST gene with hight FPKM, and two low FPKM genes with test status "OK":


    Code:
    ttest_id	status	value_1	value_2	ln(fold_change)	test_stat	p_value	significant
    NR_036659	NOTEST	1119.85	6601.74	1.774 		-54.911 	0	no
    NM_001130440	OK	5.6E-09	5.7E-09	0.030 		-1.744 		0.081	no
    NM_001001977	OK	9.7E-09	1.2E-08	0.227	 	-18.416 	0	yes
    Does somebody have some idea? :-/

    thanks
    pej
  • Boel
    Member
    • Oct 2009
    • 62

    #2
    Hi Pejman,

    Any progress with the fact that so many of the genes with "status = OK" have "Significant = yes"? Kind of seeing the same thing.

    Boel

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
      by SEQadmin2



      CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

      Despite this, “CRISPR helped turn genome editing from a specialized technique into
      ...
      07-31-2026, 11:01 AM
    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Today, 07:41 AM
    0 responses
    9 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-03-2026, 10:13 AM
    0 responses
    25 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-31-2026, 02:55 AM
    0 responses
    38 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    25 views
    0 reactions
    Last Post SEQadmin2  
    Working...